Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib helps treat severe hair loss in people over 65.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

The study identified key immune cell differences between mild and severe alopecia areata.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Combined therapy effectively improved severe alopecia areata in all patients after 6 months.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Early and proper treatment is crucial for children with allergic conjunctivitis to avoid complications.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Ruxolitinib can help regrow hair in severe alopecia areata.

Minoxidil helps hair regrowth in severe alopecia areata by changing immune cell behavior.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

3% topical minoxidil is ineffective for severe chronic alopecia areata.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Apremilast did not work for treating severe alopecia areata.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Adalimumab was safe but mostly ineffective for severe alopecia areata.